Type Public Industry Pharmaceutical Products Amitiza CEO Peter Greenleaf | Traded as NASDAQ: SCMP Founded 1996 Website sucampo.com | |
 | ||
Stock price SCMP (NASDAQ) US$ 11.10 +0.15 (+1.37%)29 Mar, 4:00 PM GMT-4 - Disclaimer Subsidiaries Sucampo Pharma Americas Inc SVPs Steven Caffé (M.d., Global Pv, Regulatory Affairs, Quality), Silvia Taylor (Investor, Relations, Corporate Affairs) Profiles | ||
Bio buzz center with peter greenleaf ceo sucampo pharmaceuticals inc
Sucampo Pharmaceuticals, Inc. is a public, American biopharmaceutical company focused on medical applications of a class of ion channel modulators called prostones.
Contents
- Bio buzz center with peter greenleaf ceo sucampo pharmaceuticals inc
- Products
- Corporate governance
- References
Products
Sucampo has two marketed products, Amitiza and Rescula. As of 2014, Takeda distributes this drug globally except for in Japan and China.
Corporate governance
The company's chief financial officer, as of 2014, was Cary J. Claiborne.
References
Sucampo Pharmaceuticals Wikipedia(Text) CC BY-SA